Trial Profile
A Clinical Trial to Study the Effects of Two Different Duration of Same Drug Albendazole in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Scan Head at the End of 6 Months
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Albendazole (Primary)
- Indications CNS infections; Cysticercosis
- Focus Therapeutic Use
- 31 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2014 New trial record